Duracyte’s implants make use of cells engineered to supply therapeutic protein, bypassing the complexities of conventional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that allow clinicians to watch and management an implant’s drug manufacturing course of.
The submit This Startup Goals to Upend Biologic Drug Manufacturing With Implantable ‘Cell Factories’ appeared first on MedCity Information.
